Within the lung cancer TME, CD14+ cells may also influence T-cell responses by expressing immunosuppressive T-cell checkpoints, as was noted in a subset of 61 patients with early and more advanced stage resected NSCLC of either histology. This evidence concerns the gene CD14 and lung cancer.